Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

iShares Russell 2000 ETF (NY:IWM)

209.03 +3.32 (+1.61%)
Official Closing Price Updated: 8:00 PM EDT, Jun 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about iShares Russell 2000 ETF

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Applied Digital Draws Praise From Analysts As AI Lease Deal Gains Traction: Retail Optimism Abounds
Analysts praised the $7 billion lease deal, prompting bullish price target hikes and signaling strong AI-driven growth potential. 
Via Stocktwits
Topics Artificial Intelligence
Exposures Artificial Intelligence
Small Caps Surge, Dollar General Stock Eyes Best Day, Crude Hits 2-Week Highs: What's Driving Markets Tuesday?
Wall Street posted modest midday gains on Tuesday, as investors digested the latest developments in President Donald Trump's trade policy agenda. 
Via Benzinga
Topics Government
Exposures Political
MARA Stock Rises As Bitcoin Production Soars in May, But Extreme Pessimism Grips Retail Crowd
MARA posted a 35% sequential increase in Bitcoin production and a 38% jump in blocks mined. 
Via Stocktwits
Vera Therapeutics Enters $500M Credit Facility As It Nears FDA Filing For Kidney Disease Drug: Retail Sees Stock Touching $40
The new credit facility features a lower interest rate, increasing capital availability and financial flexibility, the company stated. 
Via Stocktwits
Exposures Product Safety
Dow, Nasdaq Futures Dip As Trade, Fiscal Uncertainties Abound — But Strategist Says Current Market Recovery Is ‘Real’
More Fed speakers are lined up for the day ahead of the “Blackout period,” which kicks in this Saturday. 
Via Stocktwits
Topics Economy Government Stocks
Exposures Fossil Fuels Interest Rates Political
Trump Sets July 4 Deadline For His ‘One Big, Beautiful’ Tax Bill — But GOP Unity Still Elusive
His rallying call comes even as the House narrowly passed the bill, which is now headed toward the Senate for clearance. 
Via Stocktwits
Topics Electric Vehicles Government
Exposures Electric Vehicles Political
Lyra Therapeutics Stock Skyrockets On Positive Trial Data For Its Nasal Implant: Retail’s Thrilled
LYR-210 demonstrated statistically significant improvement compared to sham control in key symptoms of chronic rhinosinusitis, such as nasal obstruction, nasal discharge, and facial pain/pressure at... 
Via Stocktwits
Exposures COVID-19 Product Safety
Verastem Announces Positive Data From Cancer Trial Conducted By Partner: Retail Turns Bullish
In a study conducted in China, GFH375, also known as VS-7375 in the U.S., showed an overall response rate of 52% in patients with pancreatic ductal adenocarcinoma and 42% in those with non-small cell... 
Via Stocktwits
Stocks Stall, Commodities Rocket As Trade, Geopolitical Tensions Resume: What's Driving Market Monday?
After delivering its strongest monthly performance since November 2023, Wall Street entered June on a cautious note, with mounting geopolitical tensions and new trade tariffs clouding investor appetite... 
Via Benzinga
Topics World Trade
Exposures Tariff
Bit Digital To Build New AI Data Center in North Carolina: Retail Believes Stock Is Undervalued
The $45 million purchase was financed using the company’s available cash, which stood at $61.3 million as of the end of March, bolstered by proceeds from its at-the-market equity offering. 
Via Stocktwits
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Economy
Applied Digital Stock Rockets 40% After $7B Deal With CoreWeave: Retail’s Exuberant
The agreements, each spanning roughly 15 years, will enable Applied Digital to deliver 250 megawatts of critical IT power to support CoreWeave’s AI and HPC systems at its data center complex in... 
Via Stocktwits
Topics Artificial Intelligence
Exposures Artificial Intelligence
Market Monitor Trends (SPY, QQQ, IWM) and Breadth June 02
The indices continue to quote close to their next resistance. While headline indices may show only minor daily fluctuations, the underlying breadth data paints a more fragile picture. 
Via Chartmill
Nasdaq Futures Drop As Traders Await Tariff News, Powell Speech — Strategist Backs Small-Caps In 'New Bull Market'
The week’s economic calendar is heavily loaded with labor market data and speeches by Federal Reserve officials. 
Via Stocktwits
Topics Economy Government Stocks
Exposures Fossil Fuels Interest Rates Political
Wall Street Slumps As Trump Reignites China Trade Tensions, Nvidia Wipes Out Earnings Rally: What's Driving Markets Friday?
A strong May for U.S. equities is closing on a sour note, after President Donald Trump accused China of "totally" breaching a tariff agreement, raising new fears over trade disputes. 
Via Benzinga
Topics Government World Trade
Exposures Political Tariff
EXL Expands Alliance With Databricks to Boost GenAI Migration Tools: But Retail Remains Cautious
The GenAI-powered tool will automate SAS code migration, reduce manual effort, and accelerate cloud modernization across various industries. 
Via Stocktwits
Topics Artificial Intelligence
Exposures Artificial Intelligence
Rigetti Stock Declines On $350M Share Sale: Retail Thinks ‘Dip’ Isn’t Worth Buying
Following Rigetti’s announcement, retail sentiment around Rigetti on Stocktwits dipped into the ‘bearish’ territory from ‘bullish’ the previous day. 
Via Stocktwits
Zymeworks’ Drug Gets Conditional Approval For Biliary Tract Cancer Treatment In China: Retail Sentiment Refuses To Budge
Zymeworks is entitled to receive a $20 million milestone payment in connection with the NMPA approval of zanidatamab as part of its agreement with BeOne Medicines. 
Via Stocktwits
Market Monitor Trends (SPY, QQQ, IWM) and Breadth May 30
The data from May 29, 2025, confirms that market breadth has rebounded significantly, with strong participation and improving technical metrics across shorter moving averages. 
Via Chartmill
Nasdaq Futures Slip As Tariff Jitters Return — Strategist Says Lack Of ‘Earnings Collapse’ Is Market’s Saving Grace
The spotlight in Friday’s session is likely to be on the April personal income and spending report, which encompasses a key inflation measure. 
Via Stocktwits
Topics ETFs Economy Government
Exposures Fossil Fuels Interest Rates Political
Stocks Edge Higher After Court Stifles Trump Tariffs, Nvidia Rallies To 3-Month Highs, Bitcoin Dips Below $107K: What's Driving Markets Thursday?
Wall Street hovered slightly higher by midday Thursday, giving up a chunk of strong overnight gains in futures markets that were triggered by a federal court ruling suspending a large portion of... 
Via Benzinga
Topics Government
Exposures Political
Intellia Therapeutics Stock Plummets After Adverse Event In Gene Editing Therapy Study: But Retail’s Buying The Dip
The patient’s elevated levels of liver enzymes appear to be resolving without hospitalization or medical intervention, the company said. 
Via Stocktwits
Market Monitor Trends (SPY, QQQ, IWM) and Breadth May 29
The breadth indicators signal a fragile and reactive market environment, prone to sharp swings and lacking sustained leadership. Bullish momentum may struggle to gain lasting traction. 
Via Chartmill
Nasdaq Futures Rip Higher On Nvidia Earnings, Trade Court Blow To Trump Tariffs — But Analyst Stays Wary
Morgan Stanley Research says the U.S. will continue trade negotiations but not eliminate tariffs. 
Via Stocktwits
Topics Artificial Intelligence ETFs Economy
Exposures Artificial Intelligence Economy Fossil Fuels
Wall Street Stalls As Treasury Yields Climb Again Ahead Of Nvidia Earnings, Fed Minutes: What's Driving Markets Wednesday?
After a sharp Tuesday rally fueled by optimism over improved U.S.-EU trade ties, Wall Street stalled midweek as rising Treasury yields reasserted pressure ahead of Nvidia Corp. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Candel Therapeutics Stock Soars On FDA’s RMAT Designation For Prostate Cancer Therapy: Retail Considers It Good Long-Term Buy
Candel CEO Paul Peter Tak said that the company looks forward to collaborating with the FDA on an expedited approval for the immunotherapy candidate once it submits its Biologics License Application. 
Via Stocktwits
Exposures Product Safety
Abercrombie & Fitch Stock Soars After Upbeat Q1 Results: Retail Turns More Bullish
The upbeat earnings and revenue were driven by strong Hollister sales and margin expansion. 
Via Stocktwits
Box Stock Surges Post Strong Q1, Wall Street Lifts Price Target: Retail’s Exuberant
Box’s Q1 earnings and revenue beat prompts analysts at Raymond James, Morgan Stanley, and JPMorgan to raise price targets and express confidence in future growth. 
Via Stocktwits
Market Monitor Trends (SPY, QQQ, IWM) and Breadth May 28
The May 27 surge in breadth confirms the bullish price action observed across major indices on that day, reinforcing the move’s credibility. 
Via Chartmill
Nasdaq, S&P 500 Futures Tread Water Ahead Of Nvidia Earnings, Fed Minutes: Economist Says Markets Coming To Terms With ‘Trumpian Volatility’
A strategist braces for more and stronger gains ahead, citing a snapping of a long bearish streak in a key investor sentiment measure. 
Via Stocktwits
Topics Artificial Intelligence Economy Stocks
Exposures Artificial Intelligence Economy Fossil Fuels
Wall Street Rockets As Bond Yields Drop, Tesla Hits 3-Month Highs: What's Driving Markets Tuesday?
Wall Street charged higher Tuesday, with U.S. equities posting broad-based gains by midday as investors embraced a risk-on mood, spurred by easing Treasury yields and renewed optimism surrounding trade... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.